These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21771706)

  • 1. Pokemon reduces Bcl-2 expression through NF-κ Bp65: A possible mechanism of hepatocellular carcinoma.
    Zhao X; Ning Q; Sun X; Tian D
    Asian Pac J Trop Med; 2011 Jun; 4(6):492-7. PubMed ID: 21771706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells.
    Zhang NN; Sun QS; Chen Z; Liu F; Jiang YY
    Mol Cell Biochem; 2013 Jan; 372(1-2):57-64. PubMed ID: 23054188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma SMMC-7721 cells].
    Huang C; Yao JY; Li ZF; Liu LY; Ni L; Song TS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1841-4. PubMed ID: 18158998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
    Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
    World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of blockade of NF-kappaB signaling pathway on cell apoptosis in cutaneous squamous cell carcinoma].
    Xia YH; Liu D; Zhang CF; Fu DD; Li M; Li ZG; Tian ZW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):179-82. PubMed ID: 21503108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pokemon silencing leads to Bim-mediated anoikis of human hepatoma cell QGY7703.
    Liu K; Liu F; Zhang N; Liu S; Jiang Y
    Int J Mol Sci; 2012; 13(5):5818-5831. PubMed ID: 22754333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity.
    Zhu X; Dai Y; Chen Z; Xie J; Zeng W; Lin Y
    Oncol Res; 2013; 20(8):377-81. PubMed ID: 23924858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA.
    Wu W; Yao D; Wang Y; Qiu L; Sai W; Yang J; Yao N; Li S; Bian Y; Wang Z; Yao D
    Tumour Biol; 2010 Dec; 31(6):605-11. PubMed ID: 20628843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.
    Zhang QL; Tian DA; Xu XJ
    Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effects of intervention of the TNFa/NF-kappaB signaling pathway activation on hepatoma cell proliferation].
    Gu X; Yao M; Wang S; Shi Y; Dong Z; Qiu L; Yao D
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):434-9. PubMed ID: 25203707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl-2 apoptotic pathway.
    Qu Y; Qu B; Wang X; Wu R; Zhang X
    Cell Biochem Funct; 2015 Jul; 33(5):320-5. PubMed ID: 26178579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
    Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
    Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
    Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
    Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
    Tan ST; Liu SY; Wu B
    Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
    Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
    Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells.
    Wang H; Cai J; Du S; Guo Z; Xin B; Wang J; Wei W; Shen X
    Cell Biochem Funct; 2017 Aug; 35(6):315-326. PubMed ID: 28845524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific RNA interference targeting Pokemon suppresses tumor growth and induces apoptosis in prostate cancer.
    Li Y; Xu S; Wang X; Shi H; Sun Z; Yang Z
    Urology; 2013 Feb; 81(2):467.e1-7. PubMed ID: 23374847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.